Defining the epidemiology of bisphosphonate-associated osteonecrosis of the jaw: prior work and current challenges

被引:44
作者
Solomon, D. H. [1 ,2 ]
Mercer, E. [2 ]
Woo, S. B. [3 ,4 ]
Avorn, J. [1 ]
Schneeweiss, S. [1 ]
Treister, N. [3 ,4 ]
机构
[1] Brigham & Womens Hosp, Div Pharmacoepidemiol, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, Div Rheumatol, Boston, MA 02115 USA
[3] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA
[4] Brigham & Womens Hosp, Dept Oral Med, Boston, MA 02115 USA
关键词
Bisphosphonate; Epidemiology; Osteonecrosis of the jaw; Osteoporosis; ORAL BISPHOSPHONATES; SURGERY; PREVALENCE;
D O I
10.1007/s00198-012-2042-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Bisphosphonate-related osteonecrosis of the jaw (BONJ) is an adverse effect of bisphosphonate use with a poorly described epidemiology in osteoporosis patients. We examined the literature and two new cohorts for BONJ. The literature suggests an incidence rate of 0.028 % to 4.3 %. Our cohort studies found an incidence of 0.02 % (95 % CI 0.004 %-0.11 %). We examined the epidemiology of BONJ associated with osteoporosis dosing of bisphosphonates. First, we systematically searched the literature about osteoporosis BONJ. Identified studies were abstracted by two authors. Second, we attempted to estimate the relative risk of BONJ among bisphosphonate users with osteoporosis. Two different large insurance databases, one from 2005-2007 and another from 2007-2010, combined with medical record review, were searched. The older dataset did not include the International Classification of Diagnoses (ICD) diagnosis code for osteonecrosis of the jaw (ONJ; ICD 733.45). Incidence rates and relative risks were estimated using Cox regression. The literature review produced nine studies of varying quality. The incidence rates for BONJ among osteoporosis patients varied from 0.028 % to 4.3 %. Two prior studies estimated the relative risk of ONJ related to bisphosphonates and found odds ratios of 7.2 and 9.2. Our attempts to estimate the incidence rate of BONJ encompassed 41,957 in the dataset from 2005-2007 and 466,645 in a separate dataset from 2007-2010. From the older dataset, we found 51 potential cases of BONJ using a broad definition of possible ONJ. One case was confirmed by a dentist for a prevalence of 0.02 % (95 % CI 0.004 %-0.11 %) among bisphosphonate users. From the newer dataset, we found 13 possible cases, but none could be confirmed. Most subjects with the ONJ diagnosis code appeared to have had an osteoporosis-related fracture and not ONJ. The literature suggests a broad range of possible values for the prevalence of BONJ; our estimate fell within the range from prior literature.
引用
收藏
页码:237 / 244
页数:8
相关论文
共 50 条
  • [41] PLATELET-RICH PLASMA IMPROVES WOUND HEALING IN MULTIPLE MYELOMA BISPHOSPHONATE-ASSOCIATED OSTEONECROSIS OF THE JAW PATIENTS
    Coviello, V.
    Peluso, F.
    Dehkhargani, S. Z.
    Verdugo, F.
    Raffaelli, L.
    Manicone, P. F.
    D'Addona, A.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2012, 26 (01) : 151 - 155
  • [42] Incidence of Bisphosphonate-associated Osteonecrosis of the Jaws in Breast Cancer Patients
    Walter, Christian
    Al-Nawas, Bilal
    du Bois, Andreas
    Buch, Laura
    Harter, Philipp
    Groetz, Knut A.
    CANCER, 2009, 115 (08) : 1631 - 1637
  • [43] Prevalence and Risk Factors of Bisphosphonate-Associated Osteonecrosis of the Jaw in Prostate Cancer Patients with Advanced Disease Treated with Zoledronate
    Walter, Christian
    Al-Nawas, Bilal
    Groetz, Knut A.
    Thomas, Christian
    Thueroff, Joachim W.
    Zinser, Viktoria
    Gamm, Heinold
    Beck, Joachim
    Wagner, Wilfried
    EUROPEAN UROLOGY, 2008, 54 (05) : 1066 - 1072
  • [44] Histopathological features of bisphosphonate-associated osteonecrosis: findings in patients treated with partial mandibulectomies
    Cho, Young-Ah
    Yoon, Hye-Jung
    Lee, Jae-Il
    Hong, Sam-Pyo
    Hong, Seong-Doo
    ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY, 2012, 114 (06): : 785 - 791
  • [45] Osteonecrosis of the Jaw in Sweden Associated With the Oral Use of Bisphosphonate
    Ulmner, Mattias
    Jarnbring, Fredrik
    Torring, Ove
    JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2014, 72 (01) : 76 - 82
  • [46] Clinical aspects of bisphosphonate-associated oral osteonecrosis in patients with multiple myeloma
    Gaglioti, Domenico
    Andriani, Alessandro
    Colasanti, Ubalbo
    Papa, Raffaele
    Villiva, Nicoletta
    Riva, Chiara
    CLINICAL CASES IN MINERAL AND BONE METABOLISM, 2006, 3 (02) : 192 - 197
  • [47] Risk factors for bisphosphonate-associated osteonecrosis of the jaw in the prospective randomized trial of adjuvant bisphosphonates for early-stage breast cancer (SWOG 0307)
    Kizub, Darya A.
    Miao, Jieling
    Schubert, Mark M.
    Paterson, Alexander H. G.
    Clemons, Mark
    Dees, Elizabeth C.
    Ingle, James N.
    Falkson, Carla I.
    Barlow, William E.
    Hortobagyi, Gabriel N.
    Gralow, Julie R.
    SUPPORTIVE CARE IN CANCER, 2021, 29 (05) : 2509 - 2517
  • [48] Risk factors for bisphosphonate-associated osteonecrosis of the jaw in the prospective randomized trial of adjuvant bisphosphonates for early-stage breast cancer (SWOG 0307)
    Darya A. Kizub
    Jieling Miao
    Mark M. Schubert
    Alexander H. G. Paterson
    Mark Clemons
    Elizabeth C. Dees
    James N. Ingle
    Carla I. Falkson
    William E. Barlow
    Gabriel N. Hortobagyi
    Julie R. Gralow
    Supportive Care in Cancer, 2021, 29 : 2509 - 2517
  • [49] Surgical treatment of bisphosphonate-associated osteonecrosis: Prognostic score and long-term results
    Reich, Waldemar
    Bilkenroth, Udo
    Schubert, Johannes
    Wickenhauser, Claudia
    Eckert, Alexander Walter
    JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY, 2015, 43 (09) : 1809 - 1822
  • [50] Osteotomy and primary wound closure in bisphosphonate-associated osteonecrosis of the jaw: a prospective clinical study with 12 months follow-up
    Stockmann, Philipp
    Vairaktaris, Eleftherios
    Wehrhan, Falk
    Seiss, Martin
    Schwarz, Stephan
    Spriewald, Bernd
    Neukam, Friedrich-Wilhelm
    Nkenke, Emeka
    SUPPORTIVE CARE IN CANCER, 2010, 18 (04) : 449 - 460